Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

234
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
234
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

177
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
177
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

221
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
221
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

134
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
134
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

322
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
322
Other Pulmonary Disorders01:17

Other Pulmonary Disorders

830
Respiratory disorders encompass a range of conditions with varying levels of severity. Asthma, marked by chronic airway inflammation and hypersensitivity, is one such condition. It can lead to airway obstruction due to factors like bronchial spasms, mucosal edema, increased mucus secretion, or epithelial damage. Asthma triggers are diverse, ranging from allergens to emotional upset, and treatment focuses on both immediate relief through bronchodilators and long-term inflammation suppression.
830

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Tuberculosis in Poland in 2022.

Przeglad epidemiologiczny·2025
Same author

Inventory study on completeness of tuberculosis case notifications in Poland in 2018.

Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin·2024
Same author

Tuberculosis incidence in foreign-born people residing in European countries in 2020.

Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin·2023
Same author

Cladribine treatment in patients with pulmonary Langerhans cell histiocytosis.

Polish archives of internal medicine·2023
Same author

The impact of comorbidities on tuberculosis treatment outcomes in Poland: a national cohort study.

Frontiers in public health·2023
Same author

Tuberculosis in Poland in 2020.

Przeglad epidemiologiczny·2023

相关实验视频

Updated: Jun 25, 2025

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
10:04

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates

Published on: September 5, 2017

18.8K

在2021年波兰的结核病.

Maria Korzeniewska-Koseła1, Stefan Wesołowski1

  • 1National Tuberculosis and Lung Diseases Research Institute, Warsaw, Poland.

Przeglad epidemiologiczny
|May 24, 2024
PubMed
概括

与2020年相比,2021年波兰结核病发病率上升了10.2%,比2020年增加了10.2%. 波兰报告的细菌学确认率高,多抗药结核病 (MDR-TB) 率低于欧盟/欧洲经济区的平均水平.

科学领域:

  • 公共卫生 公共卫生
  • 流行病学 流行病学
  • 传染性疾病 传染性疾病

背景情况:

  • 结核病 (TB) 仍然是一个重大的全球卫生挑战.
  • 了解结核病的流行病学对于有效的控制策略至关重要.
  • 波兰的结核病情况需要在欧洲趋势的背景下进行分析.

研究的目的:

  • 评估2021年波兰结核病的主要流行病学特征.
  • 将波兰的结核病数据与欧盟和欧洲经济区 (EU/EEA) 国家的结核病数据进行比较.

主要方法:

  • 分析国家结核病例数据,包括药物敏感性.
  • 包括来自波兰统计局的死亡率数据和HIV-TB同时感染的数据.
  • 利用了欧洲疾病预防控制中心和世界卫生组织的数据.

主要成果:

  • 波兰在2021年报告了3704起结核病病例,每10万人口中发生率为9.7.
  • 肺结核占95.9%的病例;1.9%的人患有多抗药性结核病 (MDR-TB).
  • 男性 (14.6/100,000) 的发病率高于女性 (5.1/100,000) 的发病率,并且随着年龄的增长而增加.

结论:

关键词:
在MDR-TB中,使用的是MDR.结核病通过培养得到证实.结核病发病率 结核病发生率格鲁兹利卡石是土壤中的一种.确认细菌学的情况.结核病 (TB) 是一种疾病.这就是Zapadalność的意义.

更多相关视频

A Tuberculosis Molecular Bacterial Load Assay TB-MBLA
10:41

A Tuberculosis Molecular Bacterial Load Assay TB-MBLA

Published on: April 30, 2020

14.0K
Polarization of M1 and M2 Human Monocyte-Derived Cells and Analysis with Flow Cytometry upon Mycobacterium tuberculosis Infection
10:43

Polarization of M1 and M2 Human Monocyte-Derived Cells and Analysis with Flow Cytometry upon Mycobacterium tuberculosis Infection

Published on: September 18, 2020

29.0K

相关实验视频

Last Updated: Jun 25, 2025

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
10:04

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates

Published on: September 5, 2017

18.8K
A Tuberculosis Molecular Bacterial Load Assay TB-MBLA
10:41

A Tuberculosis Molecular Bacterial Load Assay TB-MBLA

Published on: April 30, 2020

14.0K
Polarization of M1 and M2 Human Monocyte-Derived Cells and Analysis with Flow Cytometry upon Mycobacterium tuberculosis Infection
10:43

Polarization of M1 and M2 Human Monocyte-Derived Cells and Analysis with Flow Cytometry upon Mycobacterium tuberculosis Infection

Published on: September 18, 2020

29.0K
  • 波兰的结核病发病率从2020年到2021年增加了10.2%.
  • 与欧盟/欧洲经济区平均水平相比,波兰的细菌学确认率更高 (82.6%) 和MDR-TB率更低 (1.9%).
  • 与欧盟/欧洲经济区国家相比,波兰显示移民对结核病流行病学的影响较小.